P01.10 METABOLIC CONDITIONS DETERMINE SENSITIVITY OF GLIOMA CELLS AGAINST EPIDERMAL-GROWTH FACTOR RECEPTOR (EGFR)-INHIBITION

The epidermal growth factor (EGFR) pathway is a frequently activated oncogenic pathway in glioblastoma. Nevertheless, the clinical results using EGFR inhibitors in glioma therapy are disappoiting. The reasons for the failure of these inhibitors are unclear but may involve factors of the tumor microe...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Hartel, I.A., Wolking, S., Wanka, C., Ronellenfitsch, M.W., Steinbach, J.P., Rieger, J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2014
Aiheet:
Poster Presentations
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185443/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.103
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia